University of Toronto Consultation: Draft, Tri-Agency Open Access Policy on Publications – Mar. 26, 2025

The Division of theVice-President, Research & Innovation is encouraging researchers at theUniversity of Toronto to provide their feedback on Canada's federal grantingagencies draft, revisedTri-Agency Open Access (OA) Policy on Publications ("OA Policy") (https://science.gc.ca/site/science/en/interagency-research-funding/policies-and-guidelines/open-access/draft-revised-tri-agency-open-access-policy-publications). Canada's federal researchgranting agencies — the Canadian Institutes of Health Research (CIHR), theNatural Sciences and Engineering Research Council of Canada (NSERC), and theSocialMore

Pan-Canadian Research Connect Community – Practical Considerations for Clinical Trials in Rare Disease Drug Development – Apr 9, 2025

Pan-Canadian Research Connect Webinar Rare disease clinical trials present unique challenges, requiring innovative solutions to ensure successful study design, regulatory compliance, and patient engagement. This session will provide an invaluable opportunity to explore these complexities with leading experts in the field. Learning Objectives: Understand the Unique Challenges of Rare Disease Clinical Trials Identify key obstaclesMore